ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan
· Delayed Price · Currency is TWD 23.10
+0.25 (1.09%)
Feb 27, 2025, 1:30 PM CST
ScinoPharm Taiwan Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 339.35 | 287.06 | 353.22 | 243.47 | 282.07 | Upgrade
|
| Depreciation & Amortization | 488.28 | 461.17 | 439.47 | 381.53 | 393.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4.64 | 0.42 | 0.76 | 0.27 | 3.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.12 | -0 | -0.63 | -1.38 | -0.32 | Upgrade
|
| Loss (Gain) From Sale of Investments | 9.53 | -8.67 | 2.1 | -3.91 | 5.09 | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 0.08 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.67 | -0.07 | 0.14 | 0.12 | -0.22 | Upgrade
|
| Other Operating Activities | -22.52 | -19.71 | 3.1 | -15.95 | 8.91 | Upgrade
|
| Change in Accounts Receivable | 182.33 | -152.89 | -275.16 | 26.14 | 204.05 | Upgrade
|
| Change in Inventory | -175.18 | -347.47 | 157.63 | -81.36 | -47.96 | Upgrade
|
| Change in Accounts Payable | -20.32 | -23.99 | 55.57 | -89.98 | 58.65 | Upgrade
|
| Change in Unearned Revenue | 8.43 | 43.22 | -2.81 | 3.72 | 10.86 | Upgrade
|
| Change in Other Net Operating Assets | -66.41 | -7.95 | 40.4 | 47.17 | 28.74 | Upgrade
|
| Operating Cash Flow | 750.91 | 231.13 | 773.79 | 509.82 | 946.31 | Upgrade
|
| Operating Cash Flow Growth | 224.89% | -70.13% | 51.78% | -46.13% | 19.95% | Upgrade
|
| Capital Expenditures | -280.17 | -268.43 | -243.28 | -314.43 | -179.97 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.22 | 0.14 | 0.29 | 0.23 | 0.14 | Upgrade
|
| Sale (Purchase) of Intangibles | -8.56 | -16.29 | -6.76 | -6.89 | -3.13 | Upgrade
|
| Investment in Securities | - | - | - | 261.51 | 454.76 | Upgrade
|
| Other Investing Activities | -10.87 | 51.29 | -3.87 | -10.41 | -30.08 | Upgrade
|
| Investing Cash Flow | -293.38 | -233.29 | -253.62 | -69.98 | 241.72 | Upgrade
|
| Short-Term Debt Issued | 35.33 | 63.47 | 77.22 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 89.27 | Upgrade
|
| Total Debt Issued | 35.33 | 63.47 | 77.22 | - | 89.27 | Upgrade
|
| Short-Term Debt Repaid | -33.16 | -107.47 | - | -9.49 | -79.42 | Upgrade
|
| Long-Term Debt Repaid | -12.47 | -11.29 | -11.19 | -10.26 | -242.47 | Upgrade
|
| Total Debt Repaid | -45.63 | -118.76 | -11.19 | -19.75 | -321.89 | Upgrade
|
| Net Debt Issued (Repaid) | -10.3 | -55.29 | 66.03 | -19.75 | -232.62 | Upgrade
|
| Common Dividends Paid | -237.22 | -284.67 | -379.56 | -395.37 | -213.5 | Upgrade
|
| Other Financing Activities | 2.64 | -1.03 | -1.3 | 2.35 | 1.21 | Upgrade
|
| Financing Cash Flow | -244.89 | -340.98 | -314.83 | -412.77 | -444.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | 11.82 | -10.04 | 8.44 | -1.1 | 6.85 | Upgrade
|
| Net Cash Flow | 224.46 | -353.19 | 213.79 | 25.97 | 749.97 | Upgrade
|
| Free Cash Flow | 470.74 | -37.3 | 530.51 | 195.4 | 766.34 | Upgrade
|
| Free Cash Flow Growth | - | - | 171.50% | -74.50% | 11.64% | Upgrade
|
| Free Cash Flow Margin | 13.82% | -1.17% | 16.25% | 7.07% | 24.86% | Upgrade
|
| Free Cash Flow Per Share | 0.60 | -0.05 | 0.67 | 0.25 | 0.97 | Upgrade
|
| Cash Interest Paid | - | 9.16 | 7.89 | 6.55 | 15.33 | Upgrade
|
| Cash Income Tax Paid | - | 103.42 | 77.51 | 57.98 | 6.38 | Upgrade
|
| Levered Free Cash Flow | 425.89 | -74 | 465.34 | 91.58 | 672.65 | Upgrade
|
| Unlevered Free Cash Flow | 430.94 | -68.29 | 470.29 | 95.68 | 682.13 | Upgrade
|
| Change in Net Working Capital | -29.7 | 441.29 | -27.43 | 144.92 | -237.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.